Chemistry Reference
In-Depth Information
51. Trasi, N. and Byrn, S. (2012) Mechanically induced amorphization of drugs: a study of the
thermal behavior of cryomilled compounds.
AAPS PharmSciTech
, 13(3):772-784.
52. Schroers, J., Masuhr, A., Johnson, W.L., and Busch, R. (1999) Pronounced asymmetry in the
crystallization behavior during constant heating and cooling of a bulk metallic glass-forming
liquid.
Phys. Rev. B
, 60(17):11855-11858.
53. Muniz, P., De Toro, J.A., and Riveiro, J.M. (2004) Influence of the quenched-in nuclei on the
crystallisation of amorphous Ni80B20.
J. Magn. Magn. Mater.
, 272:E1129
E1130.
54. Wang, J.Q., Zhang, H.W., Gu, X.J., Lu, K., Sommer, F., and Mittemeijer, E. (2004) Kinetics
of primary nanocrystallization in Al-rich metallic glass with quenched-in nuclei.
Mater. Sci.
Eng. A
, 375:980-984.
55. Scudino, S., Eckert, J., and Schultz, L. (2004) Possible influence of quenched-in nuclei on
quasicrystal formation in mechanically alloyed Zr57Ti8Nb2.5Cu13.9Ni11.1Al7.5 glassy
powder.
J. Mater. Res.
, 19(8):2211-2215.
56. Van Eerdenbrugh, B. and Taylor, L.S. (2010) Small scale screening to determine the ability
of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Mol.
Pharm.
, 7(4):1328-1337.
57. Strydom, S., Liebenberg, W., Yu, L., and de Villiers, M. (2009) The effect of temperature and
moisture on the amorphous-to-crystalline transformation of stavudine.
Int. J. Pharm.
,
379(1):72-81.
58. Swiatkowski, W. (2000) Effect of different sizes of subcritical nuclei on kinetics of
transformation in the solid state.
J. Non-Cryst. Solids
, 262(1-3):162-168.
59. Tomitaka, S., Mizukami, M., Paladi, F., and Oguni, M. (2005) Thermal and dielectric studies
of 2,2
ยด
-dihydroxybenzophenone: progress of crystal nucleation and growth below the glass
transition temperature.
J. Therm. Anal. Calorim.
, 81(3):637-643.
60. Rumondor, A.C.F., Marsac, P.J., Stanford, L.A., and Taylor, L.S. (2009) Phase behavior of
poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Mol. Pharm.
, 6(5):1492-1505.
61. Ivanisevic, I. (2010) Physical stability studies of miscible amorphous solid dispersions.
J. Pharm. Sci.
, 99(9):4005-4012.
62. Patterson, D. (1982) Polymer compatibility with and without a solvent.
Polym. Eng. Sci.
,
22:64
-
73.
63. Rumondor, A.C.F., Ivanisevic, I., Bates, S., Alonzo, D.E., and Taylor, L.S. (2009) Evalua-
tion of drug-polymer miscibility in amorphous solid dispersion systems.
Pharm. Res.
,
26(11):2523-2534.
64. Konno, H. and Taylor, L.S. (2006) Influence of different polymers on the crystallization
tendency of molecularly dispersed amorphous felodipine.
J. Pharm. Sci.
, 95(12):2692-2705.
65. Six, K., Murphy, J., Weuts, I., Craig, D.Q.M., Verreck, G., Peeters, J., Brewster, M., and Van
den Mooter, G. (2003) Identification of phase separation in solid dispersions of itraconazole
and EUDRAGIT E100 using microthermal analysis.
Pharm. Res.
, 20(1):135-138.
66. Newman, A., Engers, D., Bates, S., Ivanisevic, I., Kelly, R.C., and Zografi, G. (2008)
Characterization of amorphous API: polymer mixtures using X-ray powder diffraction.
J. Pharm. Sci.
, 97(11):4840-4856.
67. Lauer, M., Siam, M., Tardio, J., Page, S., Kindt, J., and Grassmann, O. (2013) Rapid
assessment of homogeneity and stability of amorphous solid dispersions by atomic force
microscopy: from bench to batch.
Pharm. Res.
, 30(8):2010-2022.
-
